These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 1354203

  • 1. Differentiation-related expression of adhesion molecules and receptors on human neuroblastoma tissues, cell lines and variants.
    Gross N, Favre S, Beck D, Meyer M.
    Int J Cancer; 1992 Aug 19; 52(1):85-91. PubMed ID: 1354203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer- and lymphokine-activated-killer-mediated cytotoxicity.
    Correale P, Procopio A, Celio L, Caraglia M, Genua G, Coppola V, Pepe S, Normanno N, Vecchio I, Palmieri G.
    Cancer Immunol Immunother; 1992 Aug 19; 34(4):272-8. PubMed ID: 1371427
    [Abstract] [Full Text] [Related]

  • 6. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
    Altomonte M, Gloghini A, Bertola G, Gasparollo A, Carbone A, Ferrone S, Maio M.
    Cancer Res; 1993 Jul 15; 53(14):3343-8. PubMed ID: 7686816
    [Abstract] [Full Text] [Related]

  • 7. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
    Scheper RJ, Dalton WS, Grogan TM, Schlosser A, Bellamy WT, Taylor CW, Scuderi P, Spier C.
    Int J Cancer; 1991 Jun 19; 48(4):562-7. PubMed ID: 1710609
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxicity of lymphokine-activated killer cells against human neuroblastoma cells: modulation by neuroblast differentiation.
    Duan DS, Farmer D, Rayner AA, Sadee W.
    Med Pediatr Oncol; 1990 Jun 19; 18(4):339-44. PubMed ID: 1972538
    [Abstract] [Full Text] [Related]

  • 9. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H, Kiessling R, Patarroyo M, Hansson M, Handgretinger R, Grönberg A.
    Int J Cancer; 1991 Feb 20; 47(4):527-32. PubMed ID: 1671670
    [Abstract] [Full Text] [Related]

  • 10. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
    Oblakowski P, Bello-Fernandez C, Reittie JE, Heslop HE, Galatowicz G, Veys P, Wilkes S, Prentice HG, Hazlehurst G, Hoffbrand AV.
    Blood; 1991 May 01; 77(9):1996-2001. PubMed ID: 1708296
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D, Viale O, Cerruti G, Tenca C, Malorni W, Arancia G, Iosi F, Galandrini R, Velardi A, Moretta A.
    Cell Immunol; 1992 Sep 01; 143(2):389-404. PubMed ID: 1380897
    [Abstract] [Full Text] [Related]

  • 13. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells.
    Barker HF, Hamilton MS, Ball J, Drew M, Franklin IM.
    Br J Haematol; 1992 Jul 01; 81(3):331-5. PubMed ID: 1382543
    [Abstract] [Full Text] [Related]

  • 14. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.
    Takahashi T, Ishikura H, Iwai K, Takahashi C, Kato H, Tanabe T, Yoshiki T.
    Cancer Immunol Immunother; 1993 Jul 01; 36(2):76-82. PubMed ID: 8093857
    [Abstract] [Full Text] [Related]

  • 15. CD18/CD54(+CD102), CD2/CD58 pathway-independent killing of lymphokine-activated killer (LAK) cells against glioblastoma cell lines T98G and U373MG.
    Komatsu F, Kajiwara M.
    Oncol Res; 2000 Jul 01; 12(1):17-24. PubMed ID: 11061342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
    Chong AS, Boussy IA, Graf LH, Scuderi P.
    Cell Immunol; 1992 Oct 01; 144(1):69-79. PubMed ID: 1356634
    [Abstract] [Full Text] [Related]

  • 18. The development and characterization of a natural killer cell-resistant human renal cell carcinoma cell line.
    Ernstoff MS, Jaffee EM, Oeler T.
    Nat Immun; 1992 Oct 01; 11(1):17-25. PubMed ID: 1351770
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
    Foreman NK, Rill DR, Coustan-Smith E, Douglass EC, Brenner MK.
    Br J Cancer; 1993 May 01; 67(5):933-8. PubMed ID: 8494726
    [Abstract] [Full Text] [Related]

  • 20. Expression of the adhesion molecules ICAM-1 and ICAM-2 on tumor cell lines does not correlate with their susceptibility to natural killer cell-mediated cytolysis: evidence for additional ligands for effector cell beta integrins.
    Akella R, Hall RE.
    Eur J Immunol; 1992 Apr 01; 22(4):1069-74. PubMed ID: 1348028
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.